Table 2 of Yaylacioglu Tuncay, Mol Vis 2016; 22:1267-1279.


Table 2. Clinical findings of Turkish LCD1 and GCD1 patients carrying TGFBI variations.

Patient no Age/Sex Diagnosis Family history Consanguinity Age at diagnosis BCVA (OD/OS) Treatment Variation
1 28/F LCD1 + - 18 0.8/0.7 - R124C/-
2 23/F LCD1 - - 18 0.2/0.4 - R124C/-
3 45/M LCD1 + - 24 0.05/0.4 OD ALK R124C/-
4 40/M LCD1 - - 20 0.4/0.5 OD-OS PTK R124C/-
5 36/F GCD1 + + 15 0.05/0.05 OD PPK R555W/-
6 35/M GCD1 + + 20 0.05/0.3 - R555W/-
7 18/F GCD1 + - 10 0.9/0.8 - R555W/-
8 53/M GCD1 + - 30 0.4/0.4 - R555W/-
9 27/M GCD1 + - 20 0.05/0.05 OD-OS ALK R555W/R555W
10 42/F GCD1 + + 18 0.3/0.4 - R555W/-
11 26/M GCD1 - - 18 0.5/0.3 OS PTK R555W/-
12 54/F GCD1 + - 30 0.6/0.5 - R555W/-
13 40/M GCD1 + - 20 0.1/0.2 OD ALK R555W/-
14 43/M GCD1 + + 15 0.05/0.05 OD-OS PPK R555W/-
15 35/F GCD1 - - 20 0.4/0.3 - R555W/-
16 33/F GCD1 + - 18 0.8/0.7 - R555W/-.